CURIA revolutionises cancer care globally
31 March 2022 | News
The app has become the #1 Cancer App in the Play Store in India, Australia, Austria, Spain, Italy and the UAE
Image Credit: Shutterstock
CURIA, developed by Innoplexus, has now become the most decentralised ecosystem of cancer information internationally. With more than 700,000+ downloads, CURIATM is on a mission to revolutionise patient participation in the treatment journey and clinical research for cancer. With its path-breaking AI technology, CURIATM aims to be the single source of credible information and support for cancer patients.
Built over the Ontosight platform, the app uses AI technology to search 95 per cent of the Internet every day for updates to registries, drug approval sites, and clinical trial databases. The information compiled on the app is reviewed by an expert panel and provided to the app users, in a manner that only the information relevant to the patient’s cancer profile is displayed. This significantly cuts down the time spent on search and eliminates misinformation risk.
